Navigation Links
Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody
Date:1/26/2009

New data demonstrates that Angiolix has similar efficacy to Avastin alone and in combination with other chemotherapeutics, with potentially less side-effects; study validates results seen in Previous Breast Cancer Model

DALLAS, Jan. 26 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) presented new data this week on its proprietary humanized monoclonal antibody, Angiolix, which confirmed that Angiolix(R) binds with high affinity to the its target, lactadherin, resulting in anti-angiogenesis and significant tumor growth inhibition in MCF-7 and MX-1 breast cancer xenografts. Its anticancer activity is greatly enhanced when given in combination with chemotherapy. The efficacies determined for Angiolix combinations were comparable to those of Avastin combinations. The mechanism of action of Angiolix is considerably more tumor specific than that of Avastin, potentially giving fewer adverse side-effects. The preclinical studies were conducted at Imperial College London and presented at the International Congress on Anti-Cancer Treatment, a World Leading Educational Congress, held in Paris, France, Palais des Congres 3rd - 6th February 2009.

Data was also presented on the ability of Angiolix to bind to various proteins. Dr. Agamemnon Epenetos, Access Pharmaceuticals' Chief Scientific Officer, Europe explained, "Competitive binding experiments with a variety of ligands shows that Angiolix binds lactadherin selectively. This provides an excellent insight into Angiolix's tumor selective mechanism. Angiolix(R) is a promising novel agent for anti-angiogenic cancer therapy. Angiolix has proven to be an effective anticancer drug candidate, in preclinical trials, that is much more tumor specific than Avastin, because it has a tumor specific target. By comparison, Avastin binds VEGF which is widely expressed by many normal tissues and supports many essential physiological functions."

"We are d
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Wrist Access Safer, Easier for Many Patients Undergoing Minimally Invasive Treatment of Blocked Heart Arteries
2. Access Pharmaceuticals Presents New Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
3. Unprecedented 8th Year Start Up of National Direct AmeriCorps Program Access to Care Through Service (ACTS) Parent, Lead Organization The Philadelphia AIDS Consortium and World Health Care Infrastructures
4. St. Jude Study Gives New Insights Into How Cells Accessorize Their Proteins
5. McGraw-Hill Professional Launches Drug Effectiveness Resource on AccessPharmacy
6. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
7. Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac(TM) Development at Prestigious International Symposium
8. Access Pharmaceuticals Presents New Data on the Companys Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium
9. IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
10. Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing
11. IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 3SBio Inc. (NASDAQ: ... China -based biotechnology company focused ... announced today that, at an extraordinary general meeting ... in favor of the proposal to authorize and ... merger dated February 8, 2013, among Decade Sunshine ...
(Date:5/23/2013)... SAN DIEGO , May 23, 2013 Neurocrine ... Kevin Gorman , President and Chief Executive ... Bank 38 th Annual dbAccess Health Care Conference in ... Thursday, May 30 at 11:20 a.m. Eastern Time / 8:20 ... be accessed on the Company,s website at http://www.neurocrine.com . ...
(Date:5/23/2013)... May 23, 2013 Nephros, Inc. (OTC Bulletin ... device company that develops and sells high performance liquid ... rights offering.  In addition, the concurrent temporary reduction in ... on May 17, 2013. Nephros estimates that ... the rights offering.   A portion of the proceeds will ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... Amgen (Nasdaq: AMGN ) will participate in the ... St. Regis New York in New York City, beginning at ... of Global Development, for Amgen, will present at the conference. ... Internet and can be accessed from Amgen,s website, www.amgen.com ...
... Transgenomic, Inc. (OTC Bulletin Board: ... for CE IVD labeling and has significantly expanded distribution ... most of the European Union. The SURVEYOR Scan K-RAS ... of mutation detection kits, which features proprietary SURVEYOR endonuclease ...
Cached Medicine Technology:Transgenomic Expands Distribution of SURVEYOR® Scan K-RAS Mutation Detection Kit With CE IVD Mark 2Transgenomic Expands Distribution of SURVEYOR® Scan K-RAS Mutation Detection Kit With CE IVD Mark 3Transgenomic Expands Distribution of SURVEYOR® Scan K-RAS Mutation Detection Kit With CE IVD Mark 4Transgenomic Expands Distribution of SURVEYOR® Scan K-RAS Mutation Detection Kit With CE IVD Mark 5
(Date:5/24/2013)... (PRWEB) May 24, 2013 This report ... provides an overview of the risk factors and global ... (US, France, Germany, Italy, Spain, UK, Australia, and Brazil). ... of meningococcal disease segmented by age (<1, 1–4, 5–14, ... C, Y, and W-135) in these markets. The other ...
(Date:5/24/2013)... Child safety expert and author, Irene ... gifts for teachers that can "show appreciation for the ... der Zande is the founder of Kidpower, a leading ... mission is to help people create cultures of ... an incredible impact on the emotional and physical safety ...
(Date:5/24/2013)... May 24, 2013 May is National ... that weakens the bones resulting in an increased risk ... , explains “Today osteoporosis affects more than 10 million ... density, placing them at increased risk for the disease. ... one in every five diagnosed with osteoporosis is a ...
(Date:5/24/2013)... 24, 2013 Chronic Fatigue Syndrome has ... sufferers with unexplained fatigue lasting 6 months or longer. ... memory and concentration impairment, muscle and joint pain without ... un-refreshing sleep and malaise that lasts for more than ... known to be linked to insulin resistance. At a ...
(Date:5/24/2013)... British Menopause Society and Women,s Health Concern have today ... provide clarity around the role of HRT, the benefits ... society,s flagship title, Menopause International , published by ... has changed from being branded the "elixir of youth" ... used in certain circumstances. Since the publication of the ...
Breaking Medicine News(10 mins):Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 2Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 3Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 4Health News:Kidpower's 7 Tips For Parents To Find Meaningful End-Of-Year Gifts for Your Child’s Teacher 2Health News:Kidpower's 7 Tips For Parents To Find Meaningful End-Of-Year Gifts for Your Child’s Teacher 3Health News:Kidpower's 7 Tips For Parents To Find Meaningful End-Of-Year Gifts for Your Child’s Teacher 4Health News:Simple Ways to Protect Yourself from the Risks of Osteoporosis 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New hCG Diet Plans to Promote Fast Weight Loss Shown to Reduce the Risk & Symptoms of Chronic Fatigue 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New hCG Diet Plans to Promote Fast Weight Loss Shown to Reduce the Risk & Symptoms of Chronic Fatigue 3
... ... begun the new year by expanding their existing Green Bay, WI presence with the ... ... growing technology company representing both businesses and residents has joined forces with Buildmyownsite, Inc., ...
... ... them on a road to schizophrenia may be protected against some forms of cancer, according to ... ... inherit a specific form of a gene that puts them on a road to schizophrenia may ...
... emergency department, federal report shows , THURSDAY, Jan. 14 ... million motor vehicle crash victims who had injuries ranging ... a new government study finds. , About 85 percent ... 321,000 were admitted or transferred to another acute care ...
... but doing it takes reporter from the brink of ... to roll your eyes when a doctor prescribes diet and exercise as ... for me. , In the past year, I used diet and ... my cholesterol. I did it armed with knowledge given to me by ...
... , WASHINGTON , Jan. 15 ... small amount of cognitive training can cut the crash risk of older drivers ... meeting of the Transportation Research Board of the National Academy of Sciences. ... join the ranks of some 39 million drivers already over age 65. Over ...
... ... concern of hospitals is keeping their patients safe while within their facility. To ... identifiers to patients that may present a higher risk of falling while in ... for a variety of reasons, have a higher than normal risk of being ...
Cached Medicine News:Health News:Infinity Technology, Inc. Acquires Build My Own Site, Inc. 2Health News:Gene Linked to Schizophrenia May Reduce Cancer Risk 2Health News:From Risky Health Status to a Better Life 2Health News:From Risky Health Status to a Better Life 3Health News:From Risky Health Status to a Better Life 4Health News:From Risky Health Status to a Better Life 5Health News:Brain Fitness Predicts Crash Risk 2Health News:Brain Fitness Predicts Crash Risk 3Health News:Brain Fitness Predicts Crash Risk 4Health News:Midbrook Assists Local Hospital with Fall Kit Production 2Health News:Midbrook Assists Local Hospital with Fall Kit Production 3
Extremely fine straight....
Micro-Scissors "micro 2000". 12 mm, straight, extra-wide serrated handles....
Micro 2000 suture forceps light-weight instruments with blue-colored anodized round handles, extremely light weight, well balanced, easy to handle, fatigueless working, easy to maintain, corrosion-re...
Round tip, sharp all around, angled....
Medicine Products: